Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions

ανά Yu, Ai-Ming
Έκδοση 2008

Bioengineered non-coding RNA agent (BERA) in action

ανά Duan, Zhijian, Yu, Ai-Ming
Τόπος έκδοσης Bioengineered (2016)

MicroRNAs in non‐small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential

ανά Petrek, Hannah, Yu, Ai‐Ming
Τόπος έκδοσης Pharmacol Res Perspect (2019)

Cytochrome P450 and Xenobiotic Receptor Humanized Mice

ανά Gonzalez, Frank J., Yu, Ai-Ming
Έκδοση 2006

Difference in desipramine metabolic profile between wild-type and CYP2D6-humanized mice

ανά Shen, Hong-Wu, Yu, Ai-Ming
Έκδοση 2009

Bioengineering of noncoding RNAs for research agents and therapeutics

ανά Ho, Pui Yan, Yu, Ai-Ming
Τόπος έκδοσης Wiley Interdiscip Rev RNA (2016)

Advanced knowledge in drug metabolism and pharmacokinetics

ανά Yu, Ai-Ming, Zhong, Xiao-bo
Τόπος έκδοσης Acta Pharm Sin B (2016)

ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development

ανά Choi, Young Hee, Yu, Ai-Ming
Τόπος έκδοσης Curr Pharm Des (2014)

Noncoding microRNAs: small RNAs play a big role in regulation of ADME?

ανά Yu, Ai-Ming, Pan, Yu-Zhuo
Τόπος έκδοσης Acta Pharm Sin B (2012)

Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics

ανά Ning, Baitang, Yu, Dianke, Yu, Ai-Ming
Τόπος έκδοσης Biochem Pharmacol (2019)

MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting

ανά Pan, Yu-Zhuo, Gao, Wenqing, Yu, Ai-Ming
Έκδοση 2009

Effects of MicroRNA-34a on the Pharmacokinetics of Cytochrome P450 Probe Drugs in Mice

ανά Jilek, Joseph L., Tian, Ye, Yu, Ai-Ming
Τόπος έκδοσης Drug Metab Dispos (2017)

Pinoline May be Used as a Probe for CYP2D6 Activity

ανά Jiang, Xi-Ling, Shen, Hong-Wu, Yu, Ai-Ming
Έκδοση 2009

MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells

ανά Pan, Yu-Zhuo, Morris, Marilyn E., Yu, Ai-Ming
Έκδοση 2009

Development of a LC-MS/MS method to analyze 5-methoxy-N,N-dimethyltryptamine and bufotenine, and application to pharmacokinetic study

ανά Shen, Hong-Wu, Jiang, Xi-Ling, Yu, Ai-Ming
Έκδοση 2009

Drug-Metabolizing Enzyme, Transporter and Nuclear Receptor Genetically Modified Mouse Models

ανά Jiang, Xi-Ling, Gonzalez, Frank J., Yu, Ai-Ming
Έκδοση 2010

Nonlinear Pharmacokinetics of 5-Methoxy-N,N-dimethyltryptamine in Mice

ανά Shen, Hong-Wu, Jiang, Xi-Ling, Yu, Ai-Ming
Έκδοση 2011

Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT(1A) and 5-HT(2A) receptors

ανά Jiang, Xi-Ling, Shen, Hong-Wu, Yu, Ai-Ming
Τόπος έκδοσης Neuropharmacology (2015)

Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms

ανά Jiang, Xi-Ling, Shen, Hong-Wu, Yu, Ai-Ming
Τόπος έκδοσης Pharmacol Rep (2016)

RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges

ανά Yu, Ai-Ming, Choi, Young Hee, Tu, Mei-Juan
Τόπος έκδοσης Pharmacol Rev (2020)